Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q2 2021 · 10-Q
Revenue$2.49B$2.49B+37.7% vs Q2 2020 Net Income$65.90M$65.90MN/M vs Q2 2020 EPS Diluted$0.87$0.87N/M vs Q2 2020 Gross Profit$400,068,000+48.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived-$13,017,000N/M Free Cash Flowderived-$22,599,000N/M Margins · derivedGross margin16.1%+1.2 pt vs Q2 2020
Operating margin3.9%+2.7 pt vs Q2 2020
Net margin2.6%+5.7 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 3, 2021 · 34 d after period end